| 1. |
Name:
|
Claude Vaney, M.D. |
| 2. |
Title: |
Medical Director of the Neurological Rehabilitation and MS Centre, Montana, Switzerland
|
| 3. |
Medical Marijuana
Position: |
Pro
to the question "Should marijuana be a medical option?"
|
| 4. |
Reasoning: |
"Cannabis can be an effective alternative for patients that do not respond to ordinary drugs."
(International Week on MS, Basel, Switzerland 9/14/99) |
| 5. |
Credibility
Ranking: |
Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.].
|
| 6. |
Involvement: |
- Medical Director of the Neurological Rehabilitation and MS Centre
- Chief Specialist in Neurology, FMH, Berner Klinik Montana, Switzerland
- Lecturer, International Association for Cannabis as Medicine
- President, Rehabilitation In Multiple Sclerosis (RIMS)
- Board Member, the Swiss MS Society
- Study of the effects of capsulated cannabis extract in 57 patients with multiple sclerosis
|
| 7. |
Education: |
|
| 8. |
Relevant Affiliations/Honors: |
|
| 9. |
Contact Info: |
|
| 10. |
Other: |
Select Publications and Presentations:
- Co-authored "Efficacy Of Tetrahydrocannabinol In Patients Refractory To Standard Antiemetic Therapy. Efficacy, Safety And Tolerability Of An Orally Administered Cannabis Extract In The Treatment Of Spasticity In Patients With Multiple Sclerosis: A Randomized, Double-blind, Placebo-controlled, Crossover Study," Multiple Sclerosis 2004, 10(4): 417-24
- Presentated a paper at the 2001 Conference of the International Association for Cannabis as Medicine in Berlin, October 26-27
|
.org